4 ms·
New cancer therapy uses molecular ‘Trash Man’ to exploit a common cancer defense
- Gatsky 12y agoI'm not sure why this is here. It is a university press release for some preclinical data (ie only tested in the lab), with the actual paper behind a paywall. We could easily fill the front page of HN and many more with press releases for promising preclinical data. The conversion to actual therapies is probably less than 1%. The actual content of the article could be summarised in a few sentences, the rest is padding and soundbitten platitudes from scientists, usually with a stock lab photo at the top.